Contact us

  • View funds and model portfolios

    Learn more about our investment products

    How to invest with us

  • Latest insights""Events and webinars""Vanguard outlook 2025""
  • Discover Vanguard 365""

    Learn and earn CPD

    In-depth research for advisers

    Tools and resources for advisers

  • About Vanguard""Our 50 year anniversary""Contact us""

    Corporate reports

    • Contact us

    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —

    About this fund

    Fund objectives

    • The Fund employs a passive management – or indexing – investment approach and seeks to provide long-term capital growth by tracking the performance of the MSCI Europe Index (the “Index”).
    • The Index is comprised of large and mid-sized company stocks in developed markets in Europe.
    • The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.

    Fund facts

    Share class inception
    19 Dec 2013
    Minimum initial investment
    US$100,000,000.00
    Investment structure
    Irish UCITS
    Share Class Assets'
    Total Assets
    Strategy
    Index
    Asset Class
    Equity
    Domicile
    Ireland
    Dividend schedule
    —
    Tax status
    Austria, Germany and Switzerland reporting
    Currency
    USD
    Legal entity
    Vanguard Investment Series PLC
    Investment manager

    Vanguard Asset Management, Ltd.
    Europe Equity Index Team

    Benchmark
    MSCI Europe Index

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 30 Sep 2025

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 410 402 30 Sep 2025
    Median market capital 89.4 B 86.2 B 30 Sep 2025
    17.1 x 17.1 x 30 Sep 2025
    2.3 x 2.3 x 30 Sep 2025
    12.8% 12.8% 30 Sep 2025
    14.7% 14.8% 30 Sep 2025
    Portfolio turnover rate -40.0% — 30 Sep 2025

    Market allocation

    As at 30 Sep 2025

    CountryRegionFundBenchmarkVariance +/-
    United KingdomEurope 20.26% 22.41% -2.15%
    FranceEurope 15.63% 16.62% -0.99%
    GermanyEurope 15.01% 15.01% 0.00%
    SwitzerlandEurope 14.12% 14.12% 0.00%
    NetherlandsEurope 9.33% 7.52% 1.81%
    SwedenEurope 5.51% 5.51% 0.00%
    SpainEurope 5.50% 5.51% -0.01%
    ItalyEurope 4.90% 4.90% 0.00%
    DenmarkEurope 2.85% 2.90% -0.05%
    FinlandEurope 1.63% 1.63% 0.00%
    BelgiumEurope 1.61% 1.61% 0.00%
    OtherOther 1.01% 0.00% 1.01%
    NorwayEurope 0.91% 0.91% 0.00%
    IrelandEurope 0.68% 0.68% 0.00%
    AustriaEurope 0.34% 0.33% 0.01%

    Holdings details

    As at 30 Sep 2025

    Holding name% of market valueSectorRegionMarket valueShares
    ASML Holding NV 2.89389% Information Technology NL US$170,226,491.34 174,947
    SAP SE 2.11149% Information Technology DE US$124,203,681.60 463,823
    HSBC Holdings PLC 1.85339% Financials GB US$109,021,455.45 7,749,434
    Novartis AG 1.80665% Health Care CH US$106,272,161.03 844,541
    Nestle SA 1.78716% Consumer Staples CH US$105,125,565.17 1,144,699
    AstraZeneca PLC 1.76271% Health Care GB US$103,687,486.75 688,781
    Roche Holding AG 1.73418% Health Care CH US$102,008,912.59 312,287
    Shell PLC 1.58552% Energy GB US$93,264,737.59 2,617,700
    Siemens AG 1.54537% Industrials DE US$90,902,627.43 337,539
    Novo Nordisk A/S 1.31936% Health Care DK US$77,608,259.66 1,430,523

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or futures contracts.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (USD)
    US$212.18
    Change
    +US$0.020.01%
    At closure 29 Oct 2025
    NAV 52-week high
    US$212.20
    At closure 30 Oct 2025
    NAV 52-week low
    US$160.26
    At closure 30 Oct 2025
    NAV 52-week difference
    US$51.95
    Change
    +24.48%
    At closure 30 Oct 2025
    Historical Prices

    -

    Inception date

    19 Dec 2013

    Date NAV (USD)
    29 Oct 2025 US$212.1763
    28 Oct 2025 US$212.1606
    27 Oct 2025 US$212.2032
    24 Oct 2025 US$211.5305
    23 Oct 2025 US$210.9129
    22 Oct 2025 US$210.1519
    21 Oct 2025 US$210.5593
    20 Oct 2025 US$211.0129
    17 Oct 2025 US$209.0842
    16 Oct 2025 US$211.1356

    Distribution history

    Distribution frequency

    —

    Historical performance 30 Sep 2025

    3.03%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: USD

    Fund codes

    • Bloomberg: VANEIUS
    • Citi: JWGD
    • ISIN: IE00BFPM9K89
    • MEX ID: VIAABC
    • SEDOL: BFPM9K8

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.